Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 5758192, 10 pages
http://dx.doi.org/10.1155/2016/5758192
Research Article

Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients

1MTA-ELTE Immunology Research Group, Budapest, Eötvös Loránd University, Pázmány Péter s. 1/C, Budapest 1117, Hungary
2Department of Immunology, Eötvös Loránd University, Pázmány Péter s. 1/C, Budapest 1117, Hungary
3Institute of Rheumatology and Physiotherapy, Frankel Leo u. 25-29, Budapest 1023, Hungary

Received 3 August 2016; Accepted 18 October 2016

Academic Editor: David Medgyesi

Copyright © 2016 Mariann Kremlitzka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Walport, “Complement. Second of two parts,” The New England Journal of Medicine, vol. 344, no. 15, pp. 1140–1144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Walport, “Advances in immunology: complement (first of two parts),” New England Journal of Medicine, vol. 344, no. 14, pp. 1058–1066, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Carroll, “The complement system in regulation of adaptive immunity,” Nature Immunology, vol. 5, no. 10, pp. 981–986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Zhang, Y. Kimura, C. Fang et al., “Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo,” Blood, vol. 110, no. 1, pp. 228–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. R. Dykman, J. L. Cole, K. Iida, and J. P. Atkinson, “Structural heterogeneity of the C3b/C4b receptor (CR1) on human peripheral blood cells,” Journal of Experimental Medicine, vol. 157, no. 6, pp. 2160–2165, 1983. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Krych, L. Clemenza, D. Howdeshell, R. Hauhart, D. Hourcade, and J. P. Atkinson, “Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis,” The Journal of Biological Chemistry, vol. 269, no. 18, pp. 13273–13278, 1994. View at Google Scholar · View at Scopus
  7. P. W. Dempsey, M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon, “C3d of complement as a molecular adjuvant: bridging innate and acquired immunity,” Science, vol. 271, no. 5247, pp. 348–350, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. A. C. Jacobson and J. H. Weis, “Comparative functional evolution of human and mouse CR1 and CR2,” Journal of Immunology, vol. 181, no. 5, pp. 2953–2959, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Józsi, J. Prechl, Z. Bajtay, and A. Erdei, “Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes,” Journal of Immunology, vol. 168, no. 6, pp. 2782–2788, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kremlitzka, A. Polgár, L. Fülöp, E. Kiss, G. Poór, and A. Erdei, “Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients,” International Immunology, vol. 25, no. 1, pp. 25–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Voynova, A. Tchorbanov, J. Prechl et al., “An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes,” Immunology Letters, vol. 116, no. 2, pp. 168–173, 2008. View at Google Scholar · View at Scopus
  12. J. Leffler, A. A. Bengtsson, and A. M. Blom, “The complement system in systemic lupus erythematosus: an update,” Annals of the Rheumatic Diseases, vol. 73, no. 9, pp. 1601–1606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Erdei, A. Isaák, K. Török et al., “Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions,” Molecular Immunology, vol. 46, no. 14, pp. 2767–2773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Arora, J. Verma, R. Dutta, V. Marwah, A. Kumar, and N. Das, “Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus,” Molecular Immunology, vol. 41, no. 4, pp. 449–456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. V. Marquart, A. Svendsen, J. M. Rasmussen et al., “Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE),” Clinical and Experimental Immunology, vol. 101, no. 1, pp. 60–65, 1995. View at Google Scholar · View at Scopus
  16. A. Isaák, P. Gergely Jr., Z. Szekeres et al., “Physiological up-regulation of inhibitory receptors FcγRII and CR1 on memory B cells is lacking in SLE patients,” International Immunology, vol. 20, no. 2, pp. 185–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. S. Kerekov, N. M. Mihaylova, I. Grozdev et al., “Elimination of autoreactive B cells in humanized SCID mouse model of SLE,” European Journal of Immunology, vol. 41, no. 11, pp. 3301–3311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  19. D. E. Isenman, D. I. C. Kells, N. R. Cooper, H. J. Müller-Eberhard, and M. K. Pangburn, “Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties,” Biochemistry, vol. 20, no. 15, pp. 4458–4467, 1981. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Basta and C. H. Hammer, “A rapid FPLC method for purification of the third component of human and guinea pig complement,” Journal of Immunological Methods, vol. 142, no. 1, pp. 39–44, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Liang, Y. Nishioka, C. F. Reich, D. S. Pisetsky, and P. E. Lipsky, “Activation of human B cells by phosphorothioate oligodeoxynucleotides,” The Journal of Clinical Investigation, vol. 98, no. 5, pp. 1119–1129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Eckl-Dorna and F. D. Batista, “BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation,” Blood, vol. 113, no. 17, pp. 3969–3977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. A. Leadbetter, I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein, “Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors,” Nature, vol. 416, no. 6881, pp. 603–607, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. Mitchell, E. J. Enyedy, M. P. Nambiar, A. Lees, and G. C. Tsokos, “Engagement of complement receptor 2 on the surface of B cells from patients with systemic lupus erythematosus contributes to the increased responsiveness to antigen stimulation,” Lupus, vol. 11, no. 5, pp. 299–303, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. P. Prodeus, S. Goerg, L.-M. Shen et al., “A critical role for complement in maintenance of self-tolerance,” Immunity, vol. 9, no. 5, pp. 721–731, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Isnardi, Y.-S. Ng, L. Menard et al., “Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones,” Blood, vol. 115, no. 24, pp. 5026–5036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Wehr, H. Eibel, M. Masilamani et al., “A new CD21low B cell population in the peripheral blood of patients with SLE,” Clinical Immunology, vol. 113, no. 2, pp. 161–171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Dal Porto, S. B. Gauld, K. T. Merrell, D. Mills, A. E. Pugh-Bernard, and J. Cambier, “B cell antigen receptor signaling 101,” Molecular Immunology, vol. 41, no. 6-7, pp. 599–613, 2004. View at Publisher · View at Google Scholar · View at Scopus